Division of General Internal Medicine and Public Health

May 20, 2021

VUMC is pacesetter for national aspirin study

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

By Paul Govern
April 8, 2021

VUMC creates new Adult Post-acute COVID Clinic

On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.

By Paul Govern
March 31, 2021

Physician-scientists Aliyu, Tindle elected to ASCI

Vanderbilt’s Muktar Aliyu, MBBS, MPH, DrPH, and Hilary Tindle, MD, MPH, will be inducted this year into the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry.

By Bill Snyder
December 21, 2020

HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine

Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.

By Kathy Whitney
December 3, 2020

Implementation research focus of symposium hosted by VUMC

One hundred ten participants from around the country attended a three-day virtual symposium hosted by Vanderbilt University Medical Center last month that explored how Implementation Research in the Learning Healthcare System can improve the quality and delivery of health care.

By Bill Snyder
Amanda Mixon, MD, MS
November 17, 2020

Statins to be studied for prevention of dementia, disability and heart disease 

Vanderbilt University Medical Center researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease.

By Craig Boerner
September 10, 2020

Roumie to direct Master of Public Health program

Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health.
By Jake Lowary
April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.
By Bill Snyder
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
By Paul Govern
September 12, 2019

Study shows benefit of palliative care for liver disease patients

A Vanderbilt study sheds new light on the impact of palliative care.
By Jill Clendening
August 20, 2019

Quitting smoking associated with lower risk of cardiovascular disease

A new Vanderbilt study documents the great incentive for current smokers to quit.
By Matt Batcheldor
July 25, 2019

Summit highlights clinical improvement successes

A summit at Vanderbilt reviewed achievements of an ongoing regional effort to transform clinical practices in ways that would improve the quality of patient care, reduce costs and improve health outcomes
By Jill Clendening
January 10, 2019

Clinical Data Research Network primed for growth

The Mid-South Clinical Data Research Network, led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, is a collaborative effort among a group of large health care systems to support and conduct innovative comparative effectiveness research and clinical trials.
By Paul Govern
1 2 3 4 5 6 7